Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of substituted 2,3-dihydroimidazo[1,2-C]quinazolines for treating lymphomas

Use of substituted 2,3-dihydroimidazo[1,2-C]quinazolines for treating lymphomas

US Patent 10226469 · Granted Mar 12, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds, compositions and methods for cancer patient stratification and cancer2024
Inhibitor of ATR kinase for use in a method of treating a hyper-proliferative di2024
Predictive markers for ATR kinase inhibitors2023
Combination of ATR kinase inhibitors and PD-1/PD-L1 inhibitors2023
Combinations of copanlisib with anti-PD-1 antibody2023
Combination of ATR kinase inhibitors with PARP inhibitors2023
2-(morpholin-4-yl)-1,7-naphthyridines2022
Compounds, compositions and methods for cancer treatment2021
Compounds, compositions and methods for cancer patient stratification and cancer2021
Heteroarylbenzimidazole compounds2021
2-(morpholin-4-yl)-1,7-naphthyridines2020
5-substituted 2-(morpholin-4-yl)-1,7-naphthyridines2020